首页   按字顺浏览 期刊浏览 卷期浏览 Effects of two calcium channel blockers on messenger RNA expression of endothelin&hyphe...
Effects of two calcium channel blockers on messenger RNA expression of endothelin‐1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats

 

作者: Mitsuhide Naruse,   Akiyo Tanabe,   Toshirou Seki,   Chika Adachi,   Takanobu Yoshimoto,   Naoko Mishina,   Toshihiro Imaki,   Kiyoko Naruse,   Reiko Demura,   Hiroshi Demura,  

 

期刊: Journal of Hypertension  (OVID Available online 1999)
卷期: Volume 17, issue 1  

页码: 53-60

 

ISSN:0263-6352

 

年代: 1999

 

出版商: OVID

 

关键词: calcium blocker;endothelin-1;endothelial-type nitric oxide synthase;stroke-prone spontaneously hypertensive rats;cardiovascular tissue

 

数据来源: OVID

 

摘要:

ObjectiveThe aim of this study was to investigate the effects of calcium channel blockers on messenger RNA expression of endothelin-1 and endothelial-type nitric oxide synthase in the cardiovascular tissue of strokeprone spontaneously hypertensive rats (SHRSP).Materials and methodsThe calcium channel blocker nilvadipine (1.0 or 3.2 mg/kg per day) was subcutaneously administered to two groups of SHRSP, from 4 or 8 weeks of age, for 8 weeks and 4 weeks, respectively. For comparison, nifedipine (3.2mg/kg per day) was similarly administered to SHRSP from 4 weeks of age for 8 weeks. Kidney, heart, aorta and brain tissue samples were obtained when the rats were 12 weeks old. Messenger RNA expression of endothelin-1 and endothelial-type nitric oxide synthase was determined by reverse transcription-polymerase chain reaction followed by Southern blotting and a ribonuclease protection assay, respectively. Results were compared with those in untreated SHRSP and Wistar-Kyoto rats at 12 weeks of age.ResultsBoth nilvadipine and nifedipine significantly decreased blood pressure in SHRSP. Although there were no changes in the weights of the kidney and brain, there was a significant decrease in the weight of the left ventricle of the groups treated with nilvadipine (1.0 mg/kg per day: mean ± SEM 0.282 ± 0.003 g; 3.2 mg/kg per day: 0.269 ± 0.005 g) and nifedipine (1 mg/kg/day: 0.281 ± 0.012 g) for 8 weeks compared with untreated SHRSP (0.301 ± 0.004 g). Endothelin-1 messenger RNA expression, which was significantly increased by about twofold in the kidney, heart and brain of SHRSP compared with Wistar-Kyoto rats, was normalized by both calcium blockers. Endothelin-1 messenger RNA expression, which was decreased in the aorta of SHRSP, was further decreased by both calcium blockers. While there was no significant difference in endothelial-type nitric oxide synthase messenger RNA expression in the kidney, heart and aorta between the untreated SHRSP and Wistar-Kyoto rats, expression in the aorta was significantly increased in the group treated with these calcium blockers for 8 weeks from 4 weeks of age.ConclusionsThese results suggest that, in addition to their potent antihypertensive effects, calcium channel blockers may exhibit cardiovasculoprotective and renoprotective effects by modifying mRNA expression of endothelin-1 and endothelial-type nitric oxide synthase in tissue.

 

点击下载:  PDF (6853KB)



返 回